Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-11

Clinical Trial Update: Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update exploring nitazoxanide and lansoprazole-based regimens for Helicobacter pylori management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lansoprazole (Lansoprazole)
  • Nitazoxanide (nitazoxanide)

Snippet

Sponsor: National Liver Institute, Egypt | Conditions: Helicobacter Pylori | Phase 4 | Status: UNKNOWN